Cholesteryl ester transfer protein inhibition for preventing cardiovascular events: JACC review topic of the week

Cholesteryl ester transfer protein inhibition for preventing cardiovascular events: JACC review topic of the week

Cholesteryl ester transfer protein (CETP) facilitates exchange of triglycerides and cholesteryl ester between high-density lipoprotein (HDL) and apolipoprotein B100–containing lipoproteins. Evidence from genetic studies that variants in the CETP gene were associated with higher blood HDL cholesterol...

Bibliografiset tiedot
Päätekijät:	Armitage, J, Holmes, M, Preiss, D
Aineistotyyppi:	Journal article
Julkaistu:	Elsevier 2019

Samankaltaisia teoksia

Protein-Truncating Variants at the Cholesteryl Ester Transfer Protein Gene and Risk for Coronary Heart DiseaseNovelty and Significance
Tekijä: Nomura, Akihiro, et al.
Julkaistu: (2018)

In-silico approach towards identification of inhibitor for cholesteryl ester transfer protein (CETP): A novel strategy
Tekijä: Suraya Abdul Sani, et al.
Julkaistu: (2015)

Artificial intelligence in cardiovascular imaging: JACC state-of-the-art review
Tekijä: Dey, D, et al.
Julkaistu: (2019)

Investigation of the physical properties of cholesteryl ester liquid crystal and the interaction with cells
Tekijä: Wan Omar, Wan Ibtisam
Julkaistu: (2016)

Lipid-modifying agents, from statins to PCSK9 inhibitors: JACC focus seminar
Tekijä: Preiss, D, et al.
Julkaistu: (2020)

Composition of human low density lipoprotein: effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein.
Tekijä: Karpe, F, et al.
Julkaistu: (1993)

Cholesteryl ester transfer protein (CETP)Ile405Val polymorphism affects the rate of fibrosis development in chronic hepatitis C virus infection.
Tekijä: Wright, M, et al.
Julkaistu: (2003)

Development of a novel cell traction force transducer based on cholesteryl ester liquid crystals: characterisation, quantification and evaluation of a cholesteryl ester liquid crystal based single cell force transducer system
Tekijä: Chin, Fhong Soon
Julkaistu: (2011)

Characterization of alginate–gelatin–cholesteryl ester liquid crystals bioinks for extrusion bioprinting of tissue engineering scaffolds
Tekijä: Abdulmaged, Alyaa Idrees, et al.
Julkaistu: (2022)

Synthesis and characterization of a potential alginate-gelatin-cholesteryl ester liquid crystals bioink for tissue engineering applications
Tekijä: Abdulmaged Al-Flayyih, Alyaa Idrees
Julkaistu: (2022)

United Kingdom Biobank (UK Biobank): JACC Focus Seminar 6/8
Tekijä: Caleyachetty, R, et al.
Julkaistu: (2021)

SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?
Tekijä: Sattar, N, et al.
Julkaistu: (2016)

Cardiovascular disease: PCSK9 inhibition: a new player in cholesterol-lowering therapies?
Tekijä: Preiss, D, et al.
Julkaistu: (2017)

Cholesteryl-conjugated phosphorothioate oligodeoxynucleotides modulate CYP2B1 expression in vivo.
Tekijä: Desjardins, J, et al.
Julkaistu: (1995)

Primary prevention of cardiovascular events in diabetes: is there a role for aspirin?
Tekijä: Price, H, et al.
Julkaistu: (2009)

A multicenter, randomized, placebo‐controlled trial of atorvastatin for the primary prevention of cardiovascular events in patients with rheumatoid arthritis
Tekijä: Kitas, G, et al.
Julkaistu: (2019)

Fáilte Éireann: two weeks of Irish events
Tekijä: Brent Council, BC

The role of emerging risk factors in cardiovascular outcome
Tekijä: Lacey, B, et al.
Julkaistu: (2017)

Topical repellents for malaria prevention
Tekijä: Gabaldón Figueira, JC, et al.
Julkaistu: (2023)

Topical repellents for malaria prevention
Tekijä: Wagah, MG, et al.
Julkaistu: (2022)

Cholesterol- and blood pressure-lowering drug use for secondary cardiovascular prevention in 2004 - 2013 Europe
Tekijä: Achelrod, D, et al.
Julkaistu: (2016)

Twice weekly tuberculosis preventive therapy in HIV infection in Zambia.
Tekijä: Mwinga, A, et al.
Julkaistu: (1998)

Population-wide cohort study of statin use for the secondary cardiovascular disease prevention in Scotland in 2009–2017
Tekijä: Thalmann, I, et al.
Julkaistu: (2022)

Childhood cardiovascular risk factors and adult cardiovascular events
Tekijä: Jacobs, DR, et al.
Julkaistu: (2022)

Composition for preventing cardiovascular diseases
Tekijä: Ismail, Maznah, et al.
Julkaistu: (2014)

Polypill for cardiovascular disease prevention.
Tekijä: Dalton, A
Julkaistu: (2013)

Large-scale plasma lipidomic profiling identifies lipids that predict cardiovascular events in secondary prevention
Tekijä: Mundra, PA, et al.
Julkaistu: (2018)

Formulation And Evaluation Of Palm Oil Esters Based Nanoemulsion For Topical Delivery Of Ketoprofen
Tekijä: Sakeena, Mohamed Hameem Fatima
Julkaistu: (2010)

The bisphosphonate-ester apornine does not act by inhibiting protein prenylation, but enhances the effects of lovastatin on myeloma cells
Tekijä: Roelofs, A, et al.
Julkaistu: (2006)

Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials.
Tekijä: Collaboration, B
Julkaistu: (2006)

Formation of palm kernel oil esters nanoemulsion systems containing ibuprofen for topical delivery
Tekijä: Salim, Norazlinaliza
Julkaistu: (2013)

An approach to enzyme inhibition employing reversible boronate ester formation
Tekijä: Leung, I, et al.
Julkaistu: (2011)

Aspirin for prevention of cancer and cardiovascular disease.
Tekijä: Rose, P, et al.
Julkaistu: (2011)

Antiplatelet therapy use for the secondary prevention of cardiovascular disease in 2009-2017: a population-wide retrospective cohort study of Scotland
Tekijä: Thalmann, I, et al.
Julkaistu: (2022)

Quality of care for secondary cardiovascular disease prevention in 2009–2017: population-wide cohort study of antiplatelet therapy use in Scotland
Tekijä: Thalmann, I, et al.
Julkaistu: (2023)

Topic modelling of authentication events in an enterprise computer network
Tekijä: Heard, N, et al.
Julkaistu: (2016)

Cardiovascular events after intracerebral hemorrhage
Tekijä: Li, L, et al.
Julkaistu: (2022)

Cardiovascular risk scoring for the prevention of cardiovascular disease in low-resource settings
Tekijä: Collins, DRJ
Julkaistu: (2017)

Beyond ten-year risk: a cost-effectiveness analysis of statins for the primary prevention of cardiovascular disease
Tekijä: Kohli-Lynch, CN, et al.
Julkaistu: (2022)

A topical applied formulation containing illipe fat and/or ester and a method producing the same
Tekijä: Basri, Mahiran, et al.
Julkaistu: (2009)